1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-8 of 8 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2006New growth references for assessment of stature and skeletal maturation in AustraliansLin, N.; Ranjitkar, S.; Macdonald, R.; Hughes, T.; Taylor, J.; Townsend, G.
2006Five-year follow-up of patients receiving imatinib for chronic myeloid leukemiaDruker, B.; Guilhot, F.; O'Brien, S.; Gathmann, I.; Kantarjian, H.; Gattermann, N.; Deininger, M.; Silver, R.; Goldman, J.; Stone, R.; Cervantes, F.; Hochhaus, A.; Powell, B.; Gabrilove, J.; Rousselot, P.; Reiffers, J.; Cornelissen, J.; Hughes, T.; Agis, H.; Fischer, T.; et al.
2006Genetic and environmental influences on dentofacial structures and oral health: Studies of Australian twins and their familiesTownsend, G.; Richards, L.; Brearley-Messer, L.; Hughes, T.; Pinkerton, S.; Seow, K.; Gotjamanos, T.; Gully, N.; Bockmann, M.
2006Chorion type, birthweight discordance and tooth-size variability in Australian monozygotic twinsRace, J.; Townsend, G.; Hughes, T.
2006Role of allogeneic stem cell transplantation for adult chronic myeloid leukemia in the imatinib eraGrigg, A.; Hughes, T.
2006Autologous stem cell collection and autograft for patients with chronic myeloid leukemia in the era of ABL kinase inhibitors: Back to the benchHui, C.; Hughes, T.
2006OCT-1-mediated influx is a key determinant of the intraceflular uptake of imatinib but not nilotinib, (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinibWhite, D.; Saunders, V.; Dang, P.; Engler, J.; Zannettino, A.; Cambareri, A.; Quinn, S.; Manley, P.; Hughes, T.
2006Imatinib as a potential antiresorptive therapy for bone diseaseDewar, A.; Farrugia, A.; Condina, M.; To, L.; Hughes, T.; Vernon-Roberts, B.; Zannettino, A.

Discover